Subclinical Cardiovascular Disease in Type 2 Diabetes Mellitus: To Screen or Not to Screen

Overview

Journal World J Clin Cases

Publisher Baishideng Publishing Group

Specialty General Medicine

Date 2014 Sep 19

PMID 25232543

Citations 4

Authors

Juan J Chillaron

Juana A Flores-Le Roux

David Benaiges

Juan Pedro-Botet

Affiliations

Soon will be listed here.

Abstract

The prevalence of type 2 diabetes mellitus (T2DM) has risen in recent decades, and cardiovascular disease remains the leading cause of death in this population. Several clinical trials have demonstrated the benefit of tight control of risk factors on the incidence and mortality of cardiovascular disease. However, in clinical practice, few patients achieve the therapeutic goals. The current diagnostic procedures for subclinical cardiovascular disease in T2DM patients have not been shown to improve prognosis or mortality, probably because they do not categorize cardiovascular risk. Thus, clinical practice guidelines do not systematically recommend screening for subclinical atherosclerosis in these patients, although it is known that patients with extra-coronary atherosclerosis, microangiopathy and poorly-controlled cardiovascular risk factors are at high risk for cardiovascular disease. Improvements in the reliability of diagnostic tests, with fewer side effects and better cost efficiency, may better help to stratify cardiovascular risk in this group of patients, and further evaluation on this topic should be considered.

Citing Articles

Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients.

Kanda E, Suzuki A, Makino M, Tsubota H, Kanemata S, Shirakawa K Sci Rep. 2022; 12(1):20012.

PMID: 36411366 PMC: 9678863. DOI: 10.1038/s41598-022-24562-2.

Subclinical cardiovascular disease and utility of coronary artery calcium score.

Saydam C Int J Cardiol Heart Vasc. 2021; 37:100909.

PMID: 34825047 PMC: 8604741. DOI: 10.1016/j.ijcha.2021.100909.

The Association of Diurnal Blood Glucose Variability With Subclinical Cardiac Disease in Patients With Type 2 Diabetes Mellitus.

Shehab-Eldin W, El-Ashmawy A, Ahmed M, Elhelbawy N, Dawood A, Elnajjar M J Saudi Heart Assoc. 2021; 32(4):490-497.

PMID: 33537198 PMC: 7849848. DOI: 10.37616/2212-5043.1174.

Clinical Significance of Arterial Stiffness and Thickness Biomarkers in Type 2 Diabetes Mellitus: An Up-To-Date Meta-Analysis.

Yapei Y, Xiaoyan R, Sha Z, Li P, Xiao M, Shuangfeng C Med Sci Monit. 2015; 21:2467-75.

PMID: 26295503 PMC: 4548741. DOI: 10.12659/MSM.894693.

References

Nicholls S, Tuzcu E, Crowe T, Sipahi I, Schoenhagen P, Kapadia S . Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J Am Coll Cardiol. 2006; 47(10):1967-75. DOI: 10.1016/j.jacc.2005.12.058. View

Soriguer F, Goday A, Bosch-Comas A, Bordiu E, Calle-Pascual A, Carmena R . Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2011; 55(1):88-93. PMC: 3228950. DOI: 10.1007/s00125-011-2336-9. View

Berman D, Wong N, Gransar H, Miranda-Peats R, Dahlbeck J, Hayes S . Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol. 2004; 44(4):923-30. DOI: 10.1016/j.jacc.2004.06.042. View

Lee C, Folsom A, Pankow J, Brancati F . Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004; 109(7):855-60. DOI: 10.1161/01.CIR.0000116389.61864.DE. View

Boden W, ORourke R, Teo K, Hartigan P, Maron D, Kostuk W . Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356(15):1503-16. DOI: 10.1056/NEJMoa070829. View

Cano J, Baena-Diez J, Franch J, Vila J, Tello S, Sala J . Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: a population-based cohort study in southern Europe. Diabetes Care. 2010; 33(9):2004-9. PMC: 2928351. DOI: 10.2337/dc10-0560. View

Gaede P, Pedersen O . Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis. Diabetes. 2004; 53 Suppl 3:S39-47. DOI: 10.2337/diabetes.53.suppl_3.s39. View

Wackers F, Young L, Inzucchi S, Chyun D, Davey J, Barrett E . Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004; 27(8):1954-61. DOI: 10.2337/diacare.27.8.1954. View

Go A, Mozaffarian D, Roger V, Benjamin E, Berry J, Blaha M . Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014; 129(3):399-410. DOI: 10.1161/01.cir.0000442015.53336.12. View

10.

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

11.

Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A . Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation. 1989; 80(1):87-98. DOI: 10.1161/01.cir.80.1.87. View

12.

Gorter P, Visseren F, Algra A, Van der Graaf Y . The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study. Diabet Med. 2007; 24(12):1352-60. DOI: 10.1111/j.1464-5491.2007.02323.x. View

13.

Jouven X, Lemaitre R, Rea T, Sotoodehnia N, Empana J, Siscovick D . Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J. 2005; 26(20):2142-7. DOI: 10.1093/eurheartj/ehi376. View

14.

Lee D, Fearon W, Froelicher V . Clinical utility of the exercise ECG in patients with diabetes and chest pain. Chest. 2001; 119(5):1576-81. DOI: 10.1378/chest.119.5.1576. View

15.

Raggi P, Shaw L, Berman D, Callister T . Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004; 43(9):1663-9. DOI: 10.1016/j.jacc.2003.09.068. View

16.

He Z, Hedrick T, Pratt C, Verani M, Aquino V, Roberts R . Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation. 2000; 101(3):244-51. DOI: 10.1161/01.cir.101.3.244. View

17.

Valensi P, Paries J, Brulport-Cerisier V, Torremocha F, Sachs R, Vanzetto G . Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care. 2005; 28(11):2722-7. DOI: 10.2337/diacare.28.11.2722. View

18.

Frye R, August P, Brooks M, Hardison R, Kelsey S, MacGregor J . A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009; 360(24):2503-15. PMC: 2863990. DOI: 10.1056/NEJMoa0805796. View

19.

Hogan P, Dall T, Nikolov P . Economic costs of diabetes in the US in 2002. Diabetes Care. 2003; 26(3):917-32. DOI: 10.2337/diacare.26.3.917. View

20.

Golomb B, Dang T, Criqui M . Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006; 114(7):688-99. DOI: 10.1161/CIRCULATIONAHA.105.593442. View